BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 11400961)

  • 1. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.
    Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM
    J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group.
    Martin RC; Edwards MJ; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Noyes RD; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Cerrito PB; McMasters KM
    Surgery; 2000 Aug; 128(2):139-44. PubMed ID: 10922983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
    Kern KA
    J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes.
    McMasters KM; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Dirk Noyes R; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Edwards MJ
    Ann Surg; 2000 May; 231(5):724-31. PubMed ID: 10767794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
    Choi SH; Barsky SH; Chang HR
    Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The breast cancer patient with multiple sentinel nodes: when to stop?
    McCarter MD; Yeung H; Fey J; Borgen PI; Cody HS
    J Am Coll Surg; 2001 Jun; 192(6):692-7. PubMed ID: 11400962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.
    McMasters KM; Wong SL; Martin RC; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Laidley AL; McGlothin TQ; Ley PB; Brown CM; Glaser RL; Pennington RE; Turk PS; Simpson D; Cerrito PB; Edwards MJ;
    Ann Surg; 2001 May; 233(5):676-87. PubMed ID: 11360892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
    Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
    Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of lymphatic tumor burden on sentinel lymph node biopsy results.
    Wong SL; Edwards MJ; Chao C; Simpson D; McMasters KM
    Breast J; 2002; 8(4):192-8. PubMed ID: 12100110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sentinel lymph node biopsy in breast cancer.
    Weerts JM; Maweja S; Tamigneaux I; Dallemagne B; Jourdan JL; Markiewicz S; Monami B; Wahlen Ch; Lastra M; Hénon V; Gomez P; Lilet H; Dwelshauwers J; Graas MP; Focan Ch; Lipczei B; Abraham F; Jehaes C
    Acta Chir Belg; 2002 Apr; 102(2):110-3. PubMed ID: 12051082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.
    Chung MH; Ye W; Giuliano AE
    Ann Surg Oncol; 2001 Oct; 8(9):688-92. PubMed ID: 11597008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
    Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK;
    JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
    Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
    Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
    van la Parra RF; de Roos WK; Contant CM; Bavelaar-Croon CD; Barneveld PC; Bosscha K
    Eur J Surg Oncol; 2014 Oct; 40(10):1250-5. PubMed ID: 24685336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.
    Ji Y; Luo N; Jiang Y; Li Q; Wei W; Yang H; Liu J
    J Surg Res; 2017 Jul; 215():88-92. PubMed ID: 28688667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
    Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
    Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.